02.12.2012 Views

Estrogen Receptor Null Mice - Endocrine Reviews

Estrogen Receptor Null Mice - Endocrine Reviews

Estrogen Receptor Null Mice - Endocrine Reviews

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

June, 1999 ESTROGEN RECEPTOR NULL MICE 367<br />

disrupting insert is accurately removed via the conventional<br />

donor and acceptor splice sites, preserving the normal reading<br />

frame of the gene (124). Studies in three different human<br />

genes have demonstrated that point mutations resulting in a<br />

premature stop codon can lead to complete excision of the<br />

exon possessing the mutation (125, 126). Furthermore, Reed<br />

and Maniatis (127) used artificial deletions and insertions<br />

within exons of genes that normally display alternative splicing<br />

to demonstrate that the proximity of the acceptor and<br />

donor splicing sequences to one another plays a role in splicing<br />

mechanisms. It is possible that insertion of sequences as<br />

large as those used in the ERKO mice may disrupt the spatial<br />

requirements necessary for proper mRNA splicing. Therefore,<br />

the above studies, along with our experiences, are relevant<br />

to the practice of targeting genes by insertion of a large<br />

disrupting sequence possessing internal stop codons.<br />

1. Interpretation of phenotypes in receptor null mice. The use of<br />

methodologies to target and disrupt individual genes has<br />

created numerous models available for study (reviewed in<br />

Refs. 109, 110, and 128). Furthermore, this impact has been<br />

felt in several facets of the biological sciences. Although it<br />

may be initially thought that a particular gene plays no role<br />

in the physiology of certain animal systems, such as reproduction<br />

or behavior, disruption of the gene and the subsequent<br />

phenotypes often prove otherwise. Therefore, transgenic<br />

and knockout technologies have spawned a number of<br />

collaborative efforts between investigators of varied disciplines<br />

that may have never occurred.<br />

An issue that has become apparent from the numerous<br />

gene disruption studies and interdisciplinary collaborative<br />

efforts is a collection of caveats to be considered when evaluating<br />

phenotypical data from a knockout model. These have<br />

arisen mostly from the behavioral sciences (reviewed in Refs.<br />

129 and 130), but have expanding application to all areas of<br />

study provided by transgenic animals. The first of these<br />

caveats is one that may be most relevant to the steroid receptor<br />

mutant models, i.e., when studying the target tissue of<br />

an adult receptor-knockout mouse, one must realize the tissue<br />

passed through all the stages of development and “organization”<br />

in the absence of the respective receptor. Therefore,<br />

this tissue, and in essence the whole animal, cannot be<br />

assumed to be truly identical to the wild type in all aspects<br />

except for the absence of the targeted gene product. Any<br />

genetic redundancies or compensatory mechanisms that<br />

took place during development cannot be readily detected or<br />

accounted for during most experiments. Therefore, the lack<br />

of a phenotype does not necessarily discount the function of<br />

the disrupted gene in the physiology being studied. Additionally,<br />

it is difficult to distinguish between an organizational<br />

vs. activational basis for an observed deficit in a particular<br />

physiology when studying the adult mutant. For<br />

example, observed resistance to a hormone due to alterations<br />

downstream of the function of the disrupted gene may be<br />

apparent during adulthood, but may have been imprinted<br />

during development.<br />

Other caveats of interpreting data from receptor null mice<br />

are founded in the methods used to generate and maintain<br />

a line of knockout mice. The standard protocol for generating<br />

a knockout mouse involves the incorporation of embryonic<br />

stem cells of a 129 strain of mice that carry the desired<br />

mutation into the blastocyst of a C57BL/6 strain. The resulting<br />

chimeric animals are then often back-crossed to the<br />

C57BL/6 strain once again until mice homozygous for the<br />

disruption are acquired. Therefore, early generations of<br />

knockout mice are composed of a somewhat chimeric genome,<br />

especially in the chromosomal regions closest to the<br />

targeted locus. This is of special importance in behavioral<br />

studies in light of the known variations in the sexual behavior<br />

of different strains of mice (131). However, most relevant to<br />

the ERKO, significant variations in estrogen responsiveness<br />

of the female reproductive tract among the different strains<br />

of mice are also known to exist (132, 133). A recent report by<br />

Roper et al. (134) has further defined the genetic basis for the<br />

variations that exist in the effects of estradiol on classical<br />

uterine parameters in mice. These limitations can be overcome<br />

to some degree by increasing experimental sample<br />

sizes and including parental strains as a control group in all<br />

experiments (135). In addition, the various models of hormone<br />

and steroid receptor deficiency that are now available<br />

no longer make necessary the complete interpretation of data<br />

from any one model. Therefore the data from these models,<br />

when interpreted as a whole, should prove invaluable to<br />

elucidating the roles of the different sex steroid receptors in<br />

both development and adult physiology.<br />

III. Reproductive Tract Phenotypes of the Female<br />

The most well characterized estrogen target tissues are<br />

those of the mammalian female reproductive tract, comprised<br />

of the ovaries, oviducts, uterus, cervix, and vagina.<br />

Reproductive capabilities in the female are dependent on the<br />

sequential processes of differentiation during the embryonic<br />

and prenatal periods and the maturation of these tissues<br />

during puberty. Differentiation of the fetal gonads to ovaries<br />

results from a lack of the Y chromosome, and therefore the<br />

testis-determining genes, and the presence of putative, yet<br />

unidentified, autosomal ovary-determining genes (111). The<br />

ductal organs of the tract subsequently result from differentiation<br />

of the fetal ambisexual precursor, the Müllerian<br />

ducts, due to the lack of testicular hormones. Early studies<br />

indicated that the female reproductive tract is the default<br />

phenotypical sex and will differentiate and develop normally<br />

in the absence of ovaries and adrenal glands (107, 136). Therefore,<br />

it appears that estrogens are not required for differentiation<br />

and initial development of the female reproductive<br />

tract, whereas testosterone is critical to differentiation of the<br />

male genitalia. This conclusion has been reconfirmed by the<br />

male-to-female sex reversal observed in male mice homozygous<br />

for a targeted disruption of the gene encoding SF-1, a<br />

transcription factor that regulates the steroid hydroxylases in<br />

steroidogenic cells (137, 138). Despite an inability to synthesize<br />

steroids and a complete lack of gonads, all SF-1 knockout<br />

mice develop female internal genitalia, regardless of genetic<br />

sex (137). It is therefore not surprising that the �ERKO and<br />

�ERKO female mice exhibit a properly differentiated female<br />

reproductive tract possessing the constituent structures (46,<br />

47). However, estrogen insensitivity has severely disrupted<br />

sexual maturation of the whole reproductive tract in the

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!